Randomized Controlled Trial of Tirzepatide for Methamphetamine Use Disorder
Randomized Controlled Trial of Tirzepatide for Methamphetamine Use Disorder
Not yet recruiting · NCT07825857 · Registry updated 2026-09-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Randomized Controlled Trial of Tirzepatide for Methamphetamine Use Disorder | Chemically-Induced Disorders, psychiatric disorder, substance-related disorder | Not yet recruiting | Phase 2 | 2026-09-23 | NCT07825857 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Institute on Drug Abuse (NIDA) | 549 |
| University of Texas Southwestern Medical Center | 295 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Center of Substance Use and Health | San Francisco | United States | 1 |
| Oklahoma State University (OSU) Center for Health Services | Tulsa | United States | 1 |
| University of Southern California (USC) | Los Angeles | United States | 1 |
| UT Southwestern Medical Center | Dallas | United States | 5 |